Globenewswire·2025-05-14 15:35Core Insights - The company reported a 5.1% increase in unaudited group revenue for the nine months ending March 31, 2025, reaching €3.9 billion, driven by activity volume growth and the acquisition of Cosem primary care centers [3][5][21] - EBITDA remained almost stable at €441 million, reflecting a slight decrease of 0.8% compared to the previous year, primarily due to the impact of government funding changes and inflation [3][9][21] - The French market continues to face challenges with low tariffs and funding interruptions, impacting overall financial performance [3][10][13] Revenue and Activity - Revenue growth in France was 6.6%, supported by the acquisition of 12 Cosem primary care centers and an increase in patient volumes [6][21] - The company experienced a 3.2% organic sales growth, indicating solid underlying performance despite external pressures [3][5] - Total admissions in French hospitals rose, confirming the group's role in addressing the post-Covid backlog of elective care [7] Cost Management and EBITDA - EBITDA was impacted by a €25 million reduction in the French government's revenue guarantee and a €14.7 million decrease due to the government's withholding of the prudential coefficient [9][10] - Cost-saving measures, including reductions in agency staff and administrative costs, were implemented to counteract the financial pressures from inflation and funding cuts [3][10] - The EBITDA margin decreased to 11.3% from 12.0% year-on-year, reflecting the challenges faced in maintaining profitability [21] Cash Flow and Financing - Net cash flow from operating activities decreased to €282 million, down €50 million from the previous year, primarily due to unfavorable working capital variations [12][24] - The company's net financial debt as of March 31, 2025, was €3.86 billion, with a restated net leverage ratio of 5.7x, indicating a slight increase from the previous period [12][22] - The company repriced its senior debt facilities at more favorable margins, providing a long-term financing framework to support its strategic plan [4][12] Strategic Developments - The company is focused on expanding its integrated care services and enhancing patient experiences through digitalization and AI tools [3][13] - Ramsay Santé continues to engage with European governments to secure fair funding for the private healthcare sector, which plays a critical role in the overall healthcare system [13][15] - The group is investing over €200 million annually to support the evolution of care pathways across various domains [16]